Literature DB >> 2636702

Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system.

T Arendt1, Y Allen, R M Marchbanks, M M Schugens, J Sinden, P L Lantos, J A Gray.   

Abstract

Oral administration of ethanol (20% v/v) to male Sprague-Dawley rats for different periods of time up to 28 weeks resulted in profound reductions of acetylcholine content, in vitro synthesis and release of acetylcholine, choline uptake, activities of choline acetyltransferase, acetylcholinesterase and pyruvate decarboxylase, content of noradrenaline, serotonin and, to a lesser extent, dopamine throughout the brain. Changes were fully and partially reversible by a 4 weeks' ethanol-free period following a treatment of 8 and 18 weeks, respectively. They remained persistent, however, after 28 weeks of treatment. Performance in an eight arm-radial maze revealed a severe impairment in both spatial and non-spatial reference and working memory. A similar pattern of memory impairment was obtained after ibotenate lesion of the cholinergic basal forebrain projection system. In order to test whether this memory impairment depends on cholinergic deafferentation of the cortex, cholinergic-rich fetal basal forebrain cell suspensions were transplanted into cortex, hippocampus or both these sites in ethanol treated rats. Cholinergic-rich transplants, but not cholinergic-poor transplants, were effective in ameliorating impaired memory function and measures of cholinergic activity in the basal forebrain projection system. The behavioural efficacy of the basal forebrain grafts was well correlated with measures of both transplant volume and the degree to which they restored acetylcholine content at the transplant site; these transplants had no effect, however, on brain monoamine levels. The effects of the cholinergic-rich transplants into cortical and hippocampal sites were additive in their amelioration of performance in the radial maze. Similarly, ibotenate lesions of the sites of origin of the cholinergic projections to neocortex (in the region of the nucleus basalis magnocellularis) and hippocampus (the medial septal areas and nucleus of the diagonal band), respectively, were additive in their deleterious effects on maze performance. There were no qualitative differences in the susceptibility of the four different types of memory performance measured (spatial and non-spatial reference and working memory) to the effects of ethanol, ibotenate lesions of the cholinergic projection system, or cholinergic-rich brain tissue transplants. Thus, overall, the results indicate that the forebrain cholinergic system acts as a whole, without major functional differences between the projections originating in the medial septal area/diagonal band complex and the basal nucleus, and that it discharges a very general function in cognitive processes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2636702     DOI: 10.1016/0306-4522(89)90397-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

1.  Correlations among central serotonergic parameters and age-related emotional and cognitive changes assessed through the elevated T-maze and the Morris water maze.

Authors:  Luciana Oliveira; Frederico G Graeff; Silvia R C Pereira; Ieda F Oliveira-Silva; Glaura C Franco; Angela Maria Ribeiro
Journal:  Age (Dordr)       Date:  2010-01-13

2.  D1-like dopamine receptors selectively block P/Q-type calcium channels to reduce glutamate release onto cholinergic basal forebrain neurones of immature rats.

Authors:  Toshihiko Momiyama; Yugo Fukazawa
Journal:  J Physiol       Date:  2007-01-18       Impact factor: 5.182

3.  Adolescent binge drinking alters adult brain neurotransmitter gene expression, behavior, brain regional volumes, and neurochemistry in mice.

Authors:  Leon G Coleman; Jun He; Joohwi Lee; Martin Styner; Fulton T Crews
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

4.  Can megadoses of thiamine prevent ethanol-induced damages of rat hippocampal CA1 pyramidal neurones?

Authors:  S Wenisch; T Steinmetz; B Fortmann; R Leiser; I Bitsch
Journal:  Z Ernahrungswiss       Date:  1996-09

5.  Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J J Turner; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

6.  Persistent Alterations of Accumbal Cholinergic Interneurons and Cognitive Dysfunction after Adolescent Intermittent Ethanol Exposure.

Authors:  E Galaj; B T Kipp; S B Floresco; L M Savage
Journal:  Neuroscience       Date:  2019-02-10       Impact factor: 3.590

7.  Decreased Beta(2)*-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates.

Authors:  Kelly P Cosgrove; Tracy Kloczynski; Frederic Bois; Brian Pittman; Gilles Tamagnan; John P Seibyl; John H Krystal; Julie K Staley
Journal:  Synapse       Date:  2010-09       Impact factor: 2.562

8.  Mild thiamine deficiency and chronic ethanol consumption modulate acetylcholinesterase activity change and spatial memory performance in a water maze task.

Authors:  Ieda de Fátima Oliveira-Silva; Silvia R Castanheira Pereira; Paula A Fernandes; Andrea F Ribeiro; Rita G W Pires; Angela Maria Ribeiro
Journal:  J Mol Neurosci       Date:  2014-04-29       Impact factor: 3.444

9.  Immunoidentification of cellular brain proteins associated with cognitive recovery in brain transplants.

Authors:  K M Wets; S N Patel; J Sinden; R M Marchbanks
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

Review 10.  Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines.

Authors:  A Nordberg; G Wahlström
Journal:  J Neural Transm Gen Sect       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.